Cardiovascular Research
Assay is new method for studying TAFI in cardiovascular disease
Published in Health and Medicine Week, August 15th, 2005
"New thrombin-activatable fibrinolysis inhibitor (TAFI) assays are necessary for studying the role of this fibrinolysis inhibitor in cardiovascular disease. The identification of a functional single nucleotide polymorphism (SNP) (1040C/T) leading to a TAFI-variant with increased stability but lower antigen levels has made the determination of functional activity even more essential," investigators in the Netherlands report.
A.H. Guimaraes and colleagues of TNO Prevention and Health in Leiden wrote, "Therefore, we developed a new assay for the functional...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Asthma
The incidence of adult asthma appears to be increasing - Cocaine Vaccine
Glyceride adjuvant induces protective antibodies against cocaine - Immunotherapy
Recommendations on financing vaccines in 21st century presented - AIDS-Related Emphysema
AIDS-related emphysema partly due to direct alveolar macrophage HIV-1 infection - Acetylcholine Receptors
Thymic toll-like receptor studied, increase in myasthenic patients shown - Acinetobacter Baumannii Outbreak
Carbapenem-resistant Acinetobacter baumannii cause of hospital outbreak - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
